CARGO Therapeutics, Inc. (NASDAQ: CRGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
CARGO Therapeutics, Inc. (NASDAQ: CRGX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $28.00 price target on the stock.
CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
CARGO Therapeutics to Participate in Upcoming Investor Conferences
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity